Biomarker algorithms and methods for determining the time of onset of stroke symptoms

摘要

A step of obtaining a biological sample from a p- individuals; LY96, ARG1, CA4, and at least one expression mediators of TLR expression mediator or a detecting composition comprising a combination of these expression mediators, biologically the method comprising contacting the sample, but wherein at least one of said expression mediator, associated with acute phase response in ischemic stroke to form a detectable response, step; and a detectable response 1 One or more comprising the step of correlating the time of onset of stroke symptoms, provides a method of determining the time of onset of stroke symptoms. LY96, ARG1, CA4, and at least one of the TLR expression mediator, or is specific for a combination of these expression mediators, provides a nucleic acid probe, an antibody or purified composition with a biomarker.